The COVID-19 outbreak brings into play a number of important regulatory requirements of which institutions need to be mindful.



Read our blogs

Pharma in Brief

Certain COVID-19 medical devices no longer hold urgent public health need status under Interim Order No. 2
July 22, 2021

Food and Drug Regulations amended: COVID-19 drugs and vaccines transitioned out of interim order framework
April 13, 2021

Two new interim orders update previous orders on medical devices and foreign products during pandemic
April 1, 2021

Health Canada consults on transition of interim order drugs, vaccines, and medical devices to permanent approval pathways
December 3, 2020

New Interim Order to address COVID-19-related drug shortages in Canada
October 25, 2020

New Interim Order to expedite the approval of COVID-19 drugs and vaccines
September 22, 2020

Federal Courts update guidance on COVID-19
September 10, 2020

Federal Court lifts Suspension Period
July 1, 2020

Federal Courts begin to phase out the Suspension Period
June 23, 2020

Federal Courts Extend Suspension Periods to June 15
June 2, 2020

Health Canada collaborates with international partners to address pandemic
May 7, 2020

Federal Court extends Suspension Period and expands use of virtual hearings
April 30, 2020

FCA to select cases that are ready to progress during pandemic
April 19, 2020

Health Canada issues Interim Order to address shortages of health products
April 13, 2020

Quebec maintains drug evaluation activities for listing purposes and launches clinical trials
April 13, 2020

Federal Courts Extend Suspension Period Until May 15
April 5, 2020

Brand Protection

Courts Across Canada Continue Reopening Plans
May 28, 2020

Ready, set, Zoom! Trials in the time of COVID-19
May 27, 2020

Canadian Court Openings Begin – Closure Updates May 1
May 1, 2020

Court Suspensions Continue, with Some Exceptions
April 27, 2020

Federal Court of Canada Extends Suspension Period to May 15, 2020
April 6, 2020

Deal Law Wire

Canadian Government Announces New Policy Applying “Enhanced Scrutiny” to Certain Foreign Investments During COVID-19
May 7, 2020

Financial Services: Regulation Tomorrow

OSFI sets expectations on the use of Pillar II capital buffers for banks during the pandemic
May 7, 2020

Subscribe and stay up to date with the latest legal news, information and events . . .